The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Febuxostat Tablets Market Research Report 2024
Synopsis
The main component of non-bubuxostat is non-bubuxostat, and its chemical name is 2-[(3-cyanogroup - 4-isobutyl oxygen group) phenyl] -4-methyl-5-thiazole carboxylic acid.Xanthine oxidase (XO) inhibitor for the long-term treatment of hyperuricemia with gout symptoms.
The global Febuxostat Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Febuxostat Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Febuxostat Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Febuxostat Tablets include Menarini Group, Takeda Pharmaceuticals, MACLEODS, Prinston Pharmaceutical, Alembic Pharmaceuticals, Hikma Pharmaceuticals, Lupin Limited, Mylan and Teijin Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Febuxostat Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Febuxostat Tablets.
Report Scope
The Febuxostat Tablets market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Febuxostat Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Febuxostat Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Menarini Group
Takeda Pharmaceuticals
MACLEODS
Prinston Pharmaceutical
Alembic Pharmaceuticals
Hikma Pharmaceuticals
Lupin Limited
Mylan
Teijin Pharma
Hengrui Pharma
Sun Pharma
Msn Laboratories
Golden State Medical
Novadoz Pharmaceuticals
Astellas Pharma
SK Holdings
Ipsen
Hangzhou Zhuyangxin Pharmaceutical
Jiangsu Wanbang Biochemical Pharmaceutical Group
Tianjin Pacific Pharmaceutical
Segment by Type
40 Mg Tablet
80 Mg Tablet
120 Mg Tablet
20 Mg Tablet
Segment by Application
Hyperuricemia
Tumor Lysis Syndrome
Angina Pectoris
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Febuxostat Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Febuxostat Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The main component of non-bubuxostat is non-bubuxostat, and its chemical name is 2-[(3-cyanogroup - 4-isobutyl oxygen group) phenyl] -4-methyl-5-thiazole carboxylic acid.Xanthine oxidase (XO) inhibitor for the long-term treatment of hyperuricemia with gout symptoms.
The global Febuxostat Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Febuxostat Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Febuxostat Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Febuxostat Tablets include Menarini Group, Takeda Pharmaceuticals, MACLEODS, Prinston Pharmaceutical, Alembic Pharmaceuticals, Hikma Pharmaceuticals, Lupin Limited, Mylan and Teijin Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Febuxostat Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Febuxostat Tablets.
Report Scope
The Febuxostat Tablets market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Febuxostat Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Febuxostat Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Menarini Group
Takeda Pharmaceuticals
MACLEODS
Prinston Pharmaceutical
Alembic Pharmaceuticals
Hikma Pharmaceuticals
Lupin Limited
Mylan
Teijin Pharma
Hengrui Pharma
Sun Pharma
Msn Laboratories
Golden State Medical
Novadoz Pharmaceuticals
Astellas Pharma
SK Holdings
Ipsen
Hangzhou Zhuyangxin Pharmaceutical
Jiangsu Wanbang Biochemical Pharmaceutical Group
Tianjin Pacific Pharmaceutical
Segment by Type
40 Mg Tablet
80 Mg Tablet
120 Mg Tablet
20 Mg Tablet
Segment by Application
Hyperuricemia
Tumor Lysis Syndrome
Angina Pectoris
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Febuxostat Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Febuxostat Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Febuxostat Tablets Market Overview
1.1 Product Overview and Scope of Febuxostat Tablets
1.2 Febuxostat Tablets Segment by Type
1.2.1 Global Febuxostat Tablets Market Value Comparison by Type (2024-2030)
1.2.2 40 Mg Tablet
1.2.3 80 Mg Tablet
1.2.4 120 Mg Tablet
1.2.5 20 Mg Tablet
1.3 Febuxostat Tablets Segment by Application
1.3.1 Global Febuxostat Tablets Market Value by Application: (2024-2030)
1.3.2 Hyperuricemia
1.3.3 Tumor Lysis Syndrome
1.3.4 Angina Pectoris
1.3.5 Other
1.4 Global Febuxostat Tablets Market Size Estimates and Forecasts
1.4.1 Global Febuxostat Tablets Revenue 2019-2030
1.4.2 Global Febuxostat Tablets Sales 2019-2030
1.4.3 Global Febuxostat Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Febuxostat Tablets Market Competition by Manufacturers
2.1 Global Febuxostat Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Febuxostat Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Febuxostat Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Febuxostat Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Febuxostat Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Febuxostat Tablets, Product Type & Application
2.7 Febuxostat Tablets Market Competitive Situation and Trends
2.7.1 Febuxostat Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Febuxostat Tablets Players Market Share by Revenue
2.7.3 Global Febuxostat Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Febuxostat Tablets Retrospective Market Scenario by Region
3.1 Global Febuxostat Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Febuxostat Tablets Global Febuxostat Tablets Sales by Region: 2019-2030
3.2.1 Global Febuxostat Tablets Sales by Region: 2019-2024
3.2.2 Global Febuxostat Tablets Sales by Region: 2025-2030
3.3 Global Febuxostat Tablets Global Febuxostat Tablets Revenue by Region: 2019-2030
3.3.1 Global Febuxostat Tablets Revenue by Region: 2019-2024
3.3.2 Global Febuxostat Tablets Revenue by Region: 2025-2030
3.4 North America Febuxostat Tablets Market Facts & Figures by Country
3.4.1 North America Febuxostat Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Febuxostat Tablets Sales by Country (2019-2030)
3.4.3 North America Febuxostat Tablets Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Febuxostat Tablets Market Facts & Figures by Country
3.5.1 Europe Febuxostat Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Febuxostat Tablets Sales by Country (2019-2030)
3.5.3 Europe Febuxostat Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Febuxostat Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Febuxostat Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Febuxostat Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Febuxostat Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Febuxostat Tablets Market Facts & Figures by Country
3.7.1 Latin America Febuxostat Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Febuxostat Tablets Sales by Country (2019-2030)
3.7.3 Latin America Febuxostat Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Febuxostat Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Febuxostat Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Febuxostat Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Febuxostat Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Febuxostat Tablets Sales by Type (2019-2030)
4.1.1 Global Febuxostat Tablets Sales by Type (2019-2024)
4.1.2 Global Febuxostat Tablets Sales by Type (2025-2030)
4.1.3 Global Febuxostat Tablets Sales Market Share by Type (2019-2030)
4.2 Global Febuxostat Tablets Revenue by Type (2019-2030)
4.2.1 Global Febuxostat Tablets Revenue by Type (2019-2024)
4.2.2 Global Febuxostat Tablets Revenue by Type (2025-2030)
4.2.3 Global Febuxostat Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Febuxostat Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Febuxostat Tablets Sales by Application (2019-2030)
5.1.1 Global Febuxostat Tablets Sales by Application (2019-2024)
5.1.2 Global Febuxostat Tablets Sales by Application (2025-2030)
5.1.3 Global Febuxostat Tablets Sales Market Share by Application (2019-2030)
5.2 Global Febuxostat Tablets Revenue by Application (2019-2030)
5.2.1 Global Febuxostat Tablets Revenue by Application (2019-2024)
5.2.2 Global Febuxostat Tablets Revenue by Application (2025-2030)
5.2.3 Global Febuxostat Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Febuxostat Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Menarini Group
6.1.1 Menarini Group Corporation Information
6.1.2 Menarini Group Description and Business Overview
6.1.3 Menarini Group Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Menarini Group Febuxostat Tablets Product Portfolio
6.1.5 Menarini Group Recent Developments/Updates
6.2 Takeda Pharmaceuticals
6.2.1 Takeda Pharmaceuticals Corporation Information
6.2.2 Takeda Pharmaceuticals Description and Business Overview
6.2.3 Takeda Pharmaceuticals Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Takeda Pharmaceuticals Febuxostat Tablets Product Portfolio
6.2.5 Takeda Pharmaceuticals Recent Developments/Updates
6.3 MACLEODS
6.3.1 MACLEODS Corporation Information
6.3.2 MACLEODS Description and Business Overview
6.3.3 MACLEODS Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MACLEODS Febuxostat Tablets Product Portfolio
6.3.5 MACLEODS Recent Developments/Updates
6.4 Prinston Pharmaceutical
6.4.1 Prinston Pharmaceutical Corporation Information
6.4.2 Prinston Pharmaceutical Description and Business Overview
6.4.3 Prinston Pharmaceutical Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Prinston Pharmaceutical Febuxostat Tablets Product Portfolio
6.4.5 Prinston Pharmaceutical Recent Developments/Updates
6.5 Alembic Pharmaceuticals
6.5.1 Alembic Pharmaceuticals Corporation Information
6.5.2 Alembic Pharmaceuticals Description and Business Overview
6.5.3 Alembic Pharmaceuticals Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Alembic Pharmaceuticals Febuxostat Tablets Product Portfolio
6.5.5 Alembic Pharmaceuticals Recent Developments/Updates
6.6 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Corporation Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hikma Pharmaceuticals Febuxostat Tablets Product Portfolio
6.6.5 Hikma Pharmaceuticals Recent Developments/Updates
6.7 Lupin Limited
6.6.1 Lupin Limited Corporation Information
6.6.2 Lupin Limited Description and Business Overview
6.6.3 Lupin Limited Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lupin Limited Febuxostat Tablets Product Portfolio
6.7.5 Lupin Limited Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Febuxostat Tablets Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Teijin Pharma
6.9.1 Teijin Pharma Corporation Information
6.9.2 Teijin Pharma Description and Business Overview
6.9.3 Teijin Pharma Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teijin Pharma Febuxostat Tablets Product Portfolio
6.9.5 Teijin Pharma Recent Developments/Updates
6.10 Hengrui Pharma
6.10.1 Hengrui Pharma Corporation Information
6.10.2 Hengrui Pharma Description and Business Overview
6.10.3 Hengrui Pharma Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hengrui Pharma Febuxostat Tablets Product Portfolio
6.10.5 Hengrui Pharma Recent Developments/Updates
6.11 Sun Pharma
6.11.1 Sun Pharma Corporation Information
6.11.2 Sun Pharma Febuxostat Tablets Description and Business Overview
6.11.3 Sun Pharma Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sun Pharma Febuxostat Tablets Product Portfolio
6.11.5 Sun Pharma Recent Developments/Updates
6.12 Msn Laboratories
6.12.1 Msn Laboratories Corporation Information
6.12.2 Msn Laboratories Febuxostat Tablets Description and Business Overview
6.12.3 Msn Laboratories Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Msn Laboratories Febuxostat Tablets Product Portfolio
6.12.5 Msn Laboratories Recent Developments/Updates
6.13 Golden State Medical
6.13.1 Golden State Medical Corporation Information
6.13.2 Golden State Medical Febuxostat Tablets Description and Business Overview
6.13.3 Golden State Medical Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Golden State Medical Febuxostat Tablets Product Portfolio
6.13.5 Golden State Medical Recent Developments/Updates
6.14 Novadoz Pharmaceuticals
6.14.1 Novadoz Pharmaceuticals Corporation Information
6.14.2 Novadoz Pharmaceuticals Febuxostat Tablets Description and Business Overview
6.14.3 Novadoz Pharmaceuticals Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Novadoz Pharmaceuticals Febuxostat Tablets Product Portfolio
6.14.5 Novadoz Pharmaceuticals Recent Developments/Updates
6.15 Astellas Pharma
6.15.1 Astellas Pharma Corporation Information
6.15.2 Astellas Pharma Febuxostat Tablets Description and Business Overview
6.15.3 Astellas Pharma Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Astellas Pharma Febuxostat Tablets Product Portfolio
6.15.5 Astellas Pharma Recent Developments/Updates
6.16 SK Holdings
6.16.1 SK Holdings Corporation Information
6.16.2 SK Holdings Febuxostat Tablets Description and Business Overview
6.16.3 SK Holdings Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.16.4 SK Holdings Febuxostat Tablets Product Portfolio
6.16.5 SK Holdings Recent Developments/Updates
6.17 Ipsen
6.17.1 Ipsen Corporation Information
6.17.2 Ipsen Febuxostat Tablets Description and Business Overview
6.17.3 Ipsen Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Ipsen Febuxostat Tablets Product Portfolio
6.17.5 Ipsen Recent Developments/Updates
6.18 Hangzhou Zhuyangxin Pharmaceutical
6.18.1 Hangzhou Zhuyangxin Pharmaceutical Corporation Information
6.18.2 Hangzhou Zhuyangxin Pharmaceutical Febuxostat Tablets Description and Business Overview
6.18.3 Hangzhou Zhuyangxin Pharmaceutical Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Hangzhou Zhuyangxin Pharmaceutical Febuxostat Tablets Product Portfolio
6.18.5 Hangzhou Zhuyangxin Pharmaceutical Recent Developments/Updates
6.19 Jiangsu Wanbang Biochemical Pharmaceutical Group
6.19.1 Jiangsu Wanbang Biochemical Pharmaceutical Group Corporation Information
6.19.2 Jiangsu Wanbang Biochemical Pharmaceutical Group Febuxostat Tablets Description and Business Overview
6.19.3 Jiangsu Wanbang Biochemical Pharmaceutical Group Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Jiangsu Wanbang Biochemical Pharmaceutical Group Febuxostat Tablets Product Portfolio
6.19.5 Jiangsu Wanbang Biochemical Pharmaceutical Group Recent Developments/Updates
6.20 Tianjin Pacific Pharmaceutical
6.20.1 Tianjin Pacific Pharmaceutical Corporation Information
6.20.2 Tianjin Pacific Pharmaceutical Febuxostat Tablets Description and Business Overview
6.20.3 Tianjin Pacific Pharmaceutical Febuxostat Tablets Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Tianjin Pacific Pharmaceutical Febuxostat Tablets Product Portfolio
6.20.5 Tianjin Pacific Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Febuxostat Tablets Industry Chain Analysis
7.2 Febuxostat Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Febuxostat Tablets Production Mode & Process
7.4 Febuxostat Tablets Sales and Marketing
7.4.1 Febuxostat Tablets Sales Channels
7.4.2 Febuxostat Tablets Distributors
7.5 Febuxostat Tablets Customers
8 Febuxostat Tablets Market Dynamics
8.1 Febuxostat Tablets Industry Trends
8.2 Febuxostat Tablets Market Drivers
8.3 Febuxostat Tablets Market Challenges
8.4 Febuxostat Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Febuxostat Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Febuxostat Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Febuxostat Tablets Market Competitive Situation by Manufacturers in 2023
Table 4. Global Febuxostat Tablets Sales (M Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Febuxostat Tablets Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Febuxostat Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Febuxostat Tablets Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Febuxostat Tablets Average Price (US$/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Febuxostat Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Febuxostat Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Febuxostat Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Febuxostat Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Febuxostat Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Febuxostat Tablets as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Febuxostat Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Febuxostat Tablets Sales by Region (2019-2024) & (M Pcs)
Table 18. Global Febuxostat Tablets Sales Market Share by Region (2019-2024)
Table 19. Global Febuxostat Tablets Sales by Region (2025-2030) & (M Pcs)
Table 20. Global Febuxostat Tablets Sales Market Share by Region (2025-2030)
Table 21. Global Febuxostat Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Febuxostat Tablets Revenue Market Share by Region (2019-2024)
Table 23. Global Febuxostat Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Febuxostat Tablets Revenue Market Share by Region (2025-2030)
Table 25. North America Febuxostat Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Febuxostat Tablets Sales by Country (2019-2024) & (M Pcs)
Table 27. North America Febuxostat Tablets Sales by Country (2025-2030) & (M Pcs)
Table 28. North America Febuxostat Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Febuxostat Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Febuxostat Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Febuxostat Tablets Sales by Country (2019-2024) & (M Pcs)
Table 32. Europe Febuxostat Tablets Sales by Country (2025-2030) & (M Pcs)
Table 33. Europe Febuxostat Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Febuxostat Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Febuxostat Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Febuxostat Tablets Sales by Region (2019-2024) & (M Pcs)
Table 37. Asia Pacific Febuxostat Tablets Sales by Region (2025-2030) & (M Pcs)
Table 38. Asia Pacific Febuxostat Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Febuxostat Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Febuxostat Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Febuxostat Tablets Sales by Country (2019-2024) & (M Pcs)
Table 42. Latin America Febuxostat Tablets Sales by Country (2025-2030) & (M Pcs)
Table 43. Latin America Febuxostat Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Febuxostat Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Febuxostat Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Febuxostat Tablets Sales by Country (2019-2024) & (M Pcs)
Table 47. Middle East & Africa Febuxostat Tablets Sales by Country (2025-2030) & (M Pcs)
Table 48. Middle East & Africa Febuxostat Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Febuxostat Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Febuxostat Tablets Sales (M Pcs) by Type (2019-2024)
Table 51. Global Febuxostat Tablets Sales (M Pcs) by Type (2025-2030)
Table 52. Global Febuxostat Tablets Sales Market Share by Type (2019-2024)
Table 53. Global Febuxostat Tablets Sales Market Share by Type (2025-2030)
Table 54. Global Febuxostat Tablets Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Febuxostat Tablets Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Febuxostat Tablets Revenue Market Share by Type (2019-2024)
Table 57. Global Febuxostat Tablets Revenue Market Share by Type (2025-2030)
Table 58. Global Febuxostat Tablets Price (US$/Pcs) by Type (2019-2024)
Table 59. Global Febuxostat Tablets Price (US$/Pcs) by Type (2025-2030)
Table 60. Global Febuxostat Tablets Sales (M Pcs) by Application (2019-2024)
Table 61. Global Febuxostat Tablets Sales (M Pcs) by Application (2025-2030)
Table 62. Global Febuxostat Tablets Sales Market Share by Application (2019-2024)
Table 63. Global Febuxostat Tablets Sales Market Share by Application (2025-2030)
Table 64. Global Febuxostat Tablets Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Febuxostat Tablets Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Febuxostat Tablets Revenue Market Share by Application (2019-2024)
Table 67. Global Febuxostat Tablets Revenue Market Share by Application (2025-2030)
Table 68. Global Febuxostat Tablets Price (US$/Pcs) by Application (2019-2024)
Table 69. Global Febuxostat Tablets Price (US$/Pcs) by Application (2025-2030)
Table 70. Menarini Group Corporation Information
Table 71. Menarini Group Description and Business Overview
Table 72. Menarini Group Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 73. Menarini Group Febuxostat Tablets Product
Table 74. Menarini Group Recent Developments/Updates
Table 75. Takeda Pharmaceuticals Corporation Information
Table 76. Takeda Pharmaceuticals Description and Business Overview
Table 77. Takeda Pharmaceuticals Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 78. Takeda Pharmaceuticals Febuxostat Tablets Product
Table 79. Takeda Pharmaceuticals Recent Developments/Updates
Table 80. MACLEODS Corporation Information
Table 81. MACLEODS Description and Business Overview
Table 82. MACLEODS Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 83. MACLEODS Febuxostat Tablets Product
Table 84. MACLEODS Recent Developments/Updates
Table 85. Prinston Pharmaceutical Corporation Information
Table 86. Prinston Pharmaceutical Description and Business Overview
Table 87. Prinston Pharmaceutical Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 88. Prinston Pharmaceutical Febuxostat Tablets Product
Table 89. Prinston Pharmaceutical Recent Developments/Updates
Table 90. Alembic Pharmaceuticals Corporation Information
Table 91. Alembic Pharmaceuticals Description and Business Overview
Table 92. Alembic Pharmaceuticals Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 93. Alembic Pharmaceuticals Febuxostat Tablets Product
Table 94. Alembic Pharmaceuticals Recent Developments/Updates
Table 95. Hikma Pharmaceuticals Corporation Information
Table 96. Hikma Pharmaceuticals Description and Business Overview
Table 97. Hikma Pharmaceuticals Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 98. Hikma Pharmaceuticals Febuxostat Tablets Product
Table 99. Hikma Pharmaceuticals Recent Developments/Updates
Table 100. Lupin Limited Corporation Information
Table 101. Lupin Limited Description and Business Overview
Table 102. Lupin Limited Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 103. Lupin Limited Febuxostat Tablets Product
Table 104. Lupin Limited Recent Developments/Updates
Table 105. Mylan Corporation Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 108. Mylan Febuxostat Tablets Product
Table 109. Mylan Recent Developments/Updates
Table 110. Teijin Pharma Corporation Information
Table 111. Teijin Pharma Description and Business Overview
Table 112. Teijin Pharma Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 113. Teijin Pharma Febuxostat Tablets Product
Table 114. Teijin Pharma Recent Developments/Updates
Table 115. Hengrui Pharma Corporation Information
Table 116. Hengrui Pharma Description and Business Overview
Table 117. Hengrui Pharma Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 118. Hengrui Pharma Febuxostat Tablets Product
Table 119. Hengrui Pharma Recent Developments/Updates
Table 120. Sun Pharma Corporation Information
Table 121. Sun Pharma Description and Business Overview
Table 122. Sun Pharma Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 123. Sun Pharma Febuxostat Tablets Product
Table 124. Sun Pharma Recent Developments/Updates
Table 125. Msn Laboratories Corporation Information
Table 126. Msn Laboratories Description and Business Overview
Table 127. Msn Laboratories Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 128. Msn Laboratories Febuxostat Tablets Product
Table 129. Msn Laboratories Recent Developments/Updates
Table 130. Golden State Medical Corporation Information
Table 131. Golden State Medical Description and Business Overview
Table 132. Golden State Medical Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 133. Golden State Medical Febuxostat Tablets Product
Table 134. Golden State Medical Recent Developments/Updates
Table 135. Novadoz Pharmaceuticals Corporation Information
Table 136. Novadoz Pharmaceuticals Description and Business Overview
Table 137. Novadoz Pharmaceuticals Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 138. Novadoz Pharmaceuticals Febuxostat Tablets Product
Table 139. Novadoz Pharmaceuticals Recent Developments/Updates
Table 140. Astellas Pharma Corporation Information
Table 141. Astellas Pharma Description and Business Overview
Table 142. Astellas Pharma Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 143. Astellas Pharma Febuxostat Tablets Product
Table 144. Astellas Pharma Recent Developments/Updates
Table 145. SK Holdings Corporation Information
Table 146. SK Holdings Description and Business Overview
Table 147. SK Holdings Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 148. SK Holdings Febuxostat Tablets Product
Table 149. SK Holdings Recent Developments/Updates
Table 150. Ipsen Corporation Information
Table 151. Ipsen Description and Business Overview
Table 152. Ipsen Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 153. Ipsen Febuxostat Tablets Product
Table 154. Ipsen Recent Developments/Updates
Table 155. Hangzhou Zhuyangxin Pharmaceutical Corporation Information
Table 156. Hangzhou Zhuyangxin Pharmaceutical Description and Business Overview
Table 157. Hangzhou Zhuyangxin Pharmaceutical Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 158. Hangzhou Zhuyangxin Pharmaceutical Febuxostat Tablets Product
Table 159. Hangzhou Zhuyangxin Pharmaceutical Recent Developments/Updates
Table 160. Jiangsu Wanbang Biochemical Pharmaceutical Group Corporation Information
Table 161. Jiangsu Wanbang Biochemical Pharmaceutical Group Description and Business Overview
Table 162. Jiangsu Wanbang Biochemical Pharmaceutical Group Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 163. Jiangsu Wanbang Biochemical Pharmaceutical Group Febuxostat Tablets Product
Table 164. Jiangsu Wanbang Biochemical Pharmaceutical Group Recent Developments/Updates
Table 165. Tianjin Pacific Pharmaceutical Corporation Information
Table 166. Tianjin Pacific Pharmaceutical Description and Business Overview
Table 167. Tianjin Pacific Pharmaceutical Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 168. Tianjin Pacific Pharmaceutical Febuxostat Tablets Product
Table 169. Tianjin Pacific Pharmaceutical Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Febuxostat Tablets Distributors List
Table 173. Febuxostat Tablets Customers List
Table 174. Febuxostat Tablets Market Trends
Table 175. Febuxostat Tablets Market Drivers
Table 176. Febuxostat Tablets Market Challenges
Table 177. Febuxostat Tablets Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Febuxostat Tablets
Figure 2. Global Febuxostat Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Febuxostat Tablets Market Share by Type in 2023 & 2030
Figure 4. 40 Mg Tablet Product Picture
Figure 5. 80 Mg Tablet Product Picture
Figure 6. 120 Mg Tablet Product Picture
Figure 7. 20 Mg Tablet Product Picture
Figure 8. Global Febuxostat Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Febuxostat Tablets Market Share by Application in 2023 & 2030
Figure 10. Hyperuricemia
Figure 11. Tumor Lysis Syndrome
Figure 12. Angina Pectoris
Figure 13. Other
Figure 14. Global Febuxostat Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Febuxostat Tablets Market Size (2019-2030) & (US$ Million)
Figure 16. Global Febuxostat Tablets Sales (2019-2030) & (M Pcs)
Figure 17. Global Febuxostat Tablets Average Price (US$/Pcs) & (2019-2030)
Figure 18. Febuxostat Tablets Report Years Considered
Figure 19. Febuxostat Tablets Sales Share by Manufacturers in 2023
Figure 20. Global Febuxostat Tablets Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Febuxostat Tablets Players: Market Share by Revenue in 2023
Figure 22. Febuxostat Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Febuxostat Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Febuxostat Tablets Sales Market Share by Country (2019-2030)
Figure 25. North America Febuxostat Tablets Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Febuxostat Tablets Sales Market Share by Country (2019-2030)
Figure 29. Europe Febuxostat Tablets Revenue Market Share by Country (2019-2030)
Figure 30. Germany Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Febuxostat Tablets Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Febuxostat Tablets Revenue Market Share by Region (2019-2030)
Figure 37. China Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Febuxostat Tablets Sales Market Share by Country (2019-2030)
Figure 48. Latin America Febuxostat Tablets Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Febuxostat Tablets Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Febuxostat Tablets Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE Febuxostat Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Febuxostat Tablets by Type (2019-2030)
Figure 58. Global Revenue Market Share of Febuxostat Tablets by Type (2019-2030)
Figure 59. Global Febuxostat Tablets Price (US$/Pcs) by Type (2019-2030)
Figure 60. Global Sales Market Share of Febuxostat Tablets by Application (2019-2030)
Figure 61. Global Revenue Market Share of Febuxostat Tablets by Application (2019-2030)
Figure 62. Global Febuxostat Tablets Price (US$/Pcs) by Application (2019-2030)
Figure 63. Febuxostat Tablets Value Chain
Figure 64. Febuxostat Tablets Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
